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Barrier to autointegration factor (BAF/BANF1) is a cellular DNA-binding protein found in the nucleus and
cytoplasm. Cytoplasmic BAF binds to foreign DNA and can act as a defense against vaccinia DNA
replication. To evade BAF, vaccinia expresses the B1 kinase, which phosphorylates BAF and blocks its
ability to bind DNA. Interestingly, B1 is also needed for viral intermediate gene expression via an
unknown mechanism. Therefore, we evaluated the impact of B1-BAF signaling on vaccinia transcription.
Strikingly, the decrease in vaccinia transcription caused by loss of B1 can be rescued by depletion of BAF.
The repressive action of BAF is greatest on a viral promoter, and is more modest when non-vaccinia
promoters are employed, which suggests BAF acts in a gene speciﬁc manner. These studies expand our
understanding of the role of the B1 kinase during infection and provide the ﬁrst evidence that BAF is a
defense against viral gene expression.
& 2013 Elsevier Inc. All rights reserved.Introduction
Vaccinia virus is the prototypical member of the large DNA
virus family Poxviridae. Like all poxviruses, vaccinia exhibits
signiﬁcant autonomy from the host cell and carries out its entire
lifecycle in the cytoplasm. The fact that vaccinia virus is capable of
both DNA replication and transcription in this location is unique
among DNA viruses, and is achieved by a large repertoire of virus-
encoded proteins including multisubunit DNA and RNA poly-
merases and multiple accessory factors (Ahn et al., 1990;
Amegadzie et al., 1991; Challberg and Englund, 1979; Condit
et al., 1991; Earl et al., 1986; Klemperer et al., 2001; McDonald
et al., 1997; Moss et al., 1991). Functional characterization of these
proteins over the last three decades has provided broad mechan-
istic insights into genome replication and transcription, which are
of interest to virology and cell biology alike. While poxviruses
avoid obstacles such as chromatin which nuclear viruses face,
cytoplasmic replication means that they are also challenged by
host defenses speciﬁc to that environment. In turn, viruses employ
countermeasures to inactivate the host defenses which are the
most signiﬁcant threat. Recent studies have revealed that the
product of the vaccinia B1R gene is one such countermeasure.ll rights reserved.
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the ts2 virus, which contain a point mutation within the B1 ORF
(Condit et al., 1983; Rempel et al., 1990; Rempel and Traktman,
1992; Traktman et al., 1989) provided the ﬁrst evidence of the
essential role played by B1 during the vaccinia lifecycle (Banham
and Smith, 1992; Lin et al., 1992; Rempel and Traktman, 1992).
Subsequent genetic and biochemical analysis of B1 revealed it to
be a Ser/Thr kinase essential for viral DNA replication as well as for
optimal intermediate transcription (Banham and Smith, 1992;
Kovacs et al., 2001; Lin et al., 1992), and also determined that
the lesion found in the ts2 virus abrogates B1's kinase activity. The
vaccinia B1 protein exhibits signiﬁcant homology with a family of
eukaryotic kinases now referred to as vaccinia-related kinases
(VRKs) (Nezu et al., 1997; Nichols and Traktman, 2004). Impor-
tantly, Boyle and Traktman discovered that the cellular kinase
VRK1, when expressed from the ts2 genome, rescued the DNA
replication defect exhibited by this virus (Boyle and Traktman,
2004). This study suggested that B1 and VRK1 both target the
same substrate needed to permit genome replication, and laid the
foundation for the identiﬁcation of the barrier to autointegration
factor (BAF/BANF1) as a cellular substrate of B1 and VRK1 (Wiebe
and Traktman, 2007).
BAF is a highly conserved 10-kDa DNA binding protein found in
both the cytoplasm and the nucleus of many cell types, and has
been found to be important for cell survival in multiple model
systems (Cai et al., 1998; Cox et al., 2011; Furukawa et al., 2003;
Lee and Craigie, 1998; Margalit et al., 2005, 2007; Puente et al.,
N. Ibrahim et al. / Virology 444 (2013) 363–3733642011; Zheng et al., 2000). Speciﬁcally, BAF is needed for survival
and differentiation of both human and mouse embryonic stem
cells (Cox et al., 2011). Additionally, attempts to deplete or knock
out BAF in Caenorhabditis elegans and Drosophila melanogaster
resulted in lethal phenotypes early in embryogenesis (Furukawa
et al., 2003; Margalit et al., 2007). Recent data has also provided
new insight of the importance of BAF in human disease. Speciﬁ-
cally, a point mutation within the BAF coding region causes
Nestor-Guillermo syndrome, a hereditary progeroid syndrome
(Puente et al., 2011).
Extensive in vitro biochemical and structural studies of BAF
have advanced our understanding of BAF's function and regulation
(Bradley et al., 2005; Haraguchi et al., 2001; Harris and Engelman,
2000; Ibrahim et al., 2011; Margalit et al., 2005; Segura-Totten
et al., 2002; Segura-Totten and Wilson, 2004; Umland et al., 2000).
BAF binds double-stranded DNA independent of sequence (Lee
and Craigie, 1998; Umland et al., 2000; Zheng et al., 2000), but
does not bind ssDNA, ssRNA, or dsRNA (Ibrahim et al., 2011; Lee
and Craigie, 1998). Through its ability to homodimerize, BAF can
cross-bridge DNA to form higher order nucleoprotein complexes
(Lee and Craigie, 1998; Zheng et al., 2000). Phosphorylation of BAF
by either the viral B1 or cellular VRK1 proteins strongly inhibits
BAF's ability to bind DNA, and regulates BAF in both the cytoplasm
and nucleus (Nichols et al., 2006). In the nucleus, BAF interacts
with LEM-domain proteins, histones, and transcriptional regula-
tors (Dechat et al., 2004; Furukawa, 1999; Haraguchi et al., 2001;
Lee et al., 2001; Margalit et al., 2005, Montes de Oca et al., 2005,
2009; Segura-Totten et al., 2002; Segura-Totten and Wilson, 2004;
Shumaker et al., 2001). These partners allow BAF to play an
important role during nuclear reassembly, and likely allow BAF
to modulate gene expression as well. In the cytoplasm BAF is
capable of inhibiting viral DNA replication (Wiebe and Traktman,
2007). This host defense activity of BAF depends on its DNA
binding and bridging properties and is blocked through phosphor-
ylation in the presence of active B1 kinase (Ibrahim et al., 2011).
In this manuscript, we further explore the importance of the
B1-BAF signaling axis during poxviral infection. Speciﬁcally, we
test the hypothesis that the action of BAF explains why B1 kinase is
needed for intermediate transcription as well as DNA replication.
We have determined that depletion of BAF from mouse L929 cells
rescues the transcriptional defect of the ts2 B1-deﬁcient virus.
Interestingly, the impact of BAF is greatest on the viral G8
promoter as compared with other non-vaccinia promoters exam-
ined. Thus, our data suggests that while BAF can bind any dsDNA
sequences, its ability to repress transcription is speciﬁc to the
promoter BAF is acting on. Together, these data reveal a novel
property of BAF as a transcriptional inhibitor and demonstrate that
vaccinia is an excellent model system for future characterization of
BAF's function as a regulator of gene expression.Results
The regulation of viral intermediate gene expression requires the B1
kinase independently of its role in DNA replication
Temperature sensitive vaccinia viruses with lesions in the B1
kinase (ts2 and ts25) display a primary block at the stage of DNA
replication at nonpermissive temperature (Condit et al., 1983). The
requirement for B1 at this stage is linked to its ability to inactivate
the cellular factor BAF via phosphorylation. If left unphosphory-
lated, BAF relocalizes to viral factories and impairs viral genome
replication via its ability to bind and crossbridge DNA (Ibrahim
et al., 2011; Nichols et al., 2006; Wiebe and Traktman, 2007).
Interestingly, prior to the discovery of the B1-BAF signaling axis,
Kovacs et al. have shown that B1 is also required for at least onepost replicative stage in the viral life cycle. Speciﬁcally, using a
plasmid transfection/infection approach to examine intermediate
gene expression independent of DNA replication, it was discovered
that intermediate promoter activity is impaired during infection
with ts25 (Kovacs et al., 2001). However, the mechanism through
which B1 contributes to gene expression has yet to be determined.
The goal of this present study was to further examine the role of
B1 during vaccinia intermediate gene expression and test the
hypothesis that without an active B1 kinase the cellular factor BAF
is not only able to impede DNA replication, but viral transcription as
well. To test this hypothesis, we ﬁrst worked to conﬁrm the role of B1
in intermediate gene expression as previously reported (Kovacs et al.,
2001). L929 ﬁbroblasts were transfected with plasmids expressing
ﬁreﬂy luciferase under the intermediate promoters of the G8R, A2L,
I1L genes or a synthetic intermediate promoter based on the
consensus sequence described by Yang et al. (2012). These cells were
then infected with WT or ts2 viruses at an MOI of 3 and incubated at
37 1C overnight before harvesting and measurement of luciferase
activity. A temperature of 37 1C was chosen for our studies because
we found that L929 cells are highly sensitive to heat induced stress at
39.7 1C. As we found that multiple temperature-sensitive viruses
retain their ts phenotype at 37 1C in L929 cells (see Fig. 2 below), we
chose to employ this temperature in our studies to minimize the
impact of unknown stress responses on the interpretation of our
data. To examine viral intermediate gene expression independent of
DNA replication, the nucleoside analog cytosine arabinoside (AraC)
was added during the infection, as previous studies have shown that
the expression of vaccinia genes from a plasmid introduced into
infected cells does not require viral DNA replication (Keck et al., 1990;
Vos and Stunnenberg, 1988). As shown in Fig. 1A, expression from
pG8-Luciferase (pG8-Luc) is inhibited in ts2-infected cells over 200-
fold compared to WT-infected cells. This is in line with the previous
observation by Kovacs et al. that the presence of a functional
B1 kinase is necessary for the viral intermediate gene expression.
Likewise, activation of each of the A2L, I1L, and consensus inter-
mediate promoters was signiﬁcantly decreased in the ts2 infected
cells as compared to WT infected cells, demonstrating that B1 is
important for expression of intermediate genes in general. As the
pG8-Luc construct exhibited the greatest fold difference betweenWT
and ts2 infections, we focused on it for the remainder of our study to
allow for the greatest sensitivity in our assays.
Next, we tested whether the defect in intermediate gene
expression of ts2 can be rescued by expression of B1 from the
viral TK locus of the ts2 virus. Using recombinant ts2 viruses, Boyle
and Traktman demonstrated that expression of B1 from the TK
locus of the ts2 genome rescues the DNA replication defect of this
virus (Boyle and Traktman, 2004). Using the same virus, we
veriﬁed that in L929 cells the expression of B1 from the ts2 virus
rescued viral yield compared to ts2 alone at either low or high MOI
(Fig. 1C), as was previously observed in BSC40 cells (Boyle and
Traktman, 2004). We also found that luciferase activity measured
in ts2/B1 was 50-fold higher than that found in ts2-infected cells
(Fig. 1B). These results support the role of the B1 kinase during
viral intermediate gene expression, and demonstrate that expres-
sion of B1 from the ts2 genome can both rescue viral yield and
enhance viral intermediate gene expression in L929 cells.
BAF affects viral intermediate gene expression in a B1 dependent
manner
The above data indicate that the B1 kinase is required not only
for DNA replication, but intermediate gene expression as well.
To determine whether B1 is unique in functioning at both of these
stages of the viral lifecycle, we examined whether intermediate
gene expression was decreased during infection with other ts
viruses displaying blocks in DNA replication. Speciﬁcally, two ts
Fig. 1. The ts2 defect in intermediate transcription is observed on multiple promoters and is rescued by B1 expression in L929 cells. (A and B) L929 cells were
transfected with the reporter construct shown for 7 h, then infected at 37 1C with WT, ts2, or ts2/B1 as indicated (MOI¼3) in the presence of 50 μM AraC. Lysates were
prepared at 16 h after infection and assayed for luciferase activity. RLU shown is normalized to total protein measured by BCA assay. Data were obtained from three
independent experiments performed in triplicate wells. Data from a representative experiment is shown. Error bars represent the standard deviation. (C) L929 cells were
infected with WT, ts2, or ts2/B1 at MOI¼0.1 or MOI¼5 for 24 h at 37 1C. After lysates were collected virus yield was determined by a plaque titration on monolayers of BSC40
cells at 32 1C. Data were obtained from triplicate experiments, and standard deviation is presented by the error bars. (*** indicates a p-value o0.05).
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carries a mutation in the viral catalytic DNA polymerase (E9)
(McDonald and Traktman, 1994; Sridhar and Condit, 1983) and
ts24 carries a mutation in the D5 primase/helicase protein (De
Silva et al., 2007, 2009; Evans, 1992; Evans et al., 1995). First, we
veriﬁed that viral DNA replication was impaired at 37 1C during
infection with these viruses. L929 cells were infected (MOI¼3)
with WT, ts2, ts42, or ts24 and lysates were collected at 0.5 and
24 hpi for DNA quantiﬁcation using quantitative PCR. As shown in
Fig. 2A, while during WT infection viral DNA increased more than
150-fold in 24 h, ts2 DNA was increased only ∼3-fold compared to
input and no increase in DNA was detected during ts42 and ts24
infections. These data demonstrate that in L929 cells, 37 1C is a
nonpermissive temperature for each of these mutant viruses.
Next, these viruses were used to begin our examination of the
role of BAF in intermediate gene expression. First, we transduced
L929 cells with replication-incompetent lentiviral vectors expres-
sing either a BAF-speciﬁc or control (CTRL) shRNA. Immunoblot
analysis of lysates from these cells revealed that expression of BAF
in L929-shBAF cells is decreased to 15–20% compared to that from
the untransduced L929 cells, while no impact on BAF expression
was detectable in the shCTRL cells (Fig. 2B). Next, L929-Control
and -shBAF cells were transfected with pG8-Luc, then infected
with WT, ts2, ts42 or ts24 viruses (MOI¼3) in the presence of AraC
for 16–20 h prior to harvest and measurement of luciferase
activity. In L929-shControl cells (Fig. 2C, left), we found thatpG8-Luc reporter activity in cells infected with ts24 was identical
to WT infection, and ts42 were only slightly (2.5-fold) reduced.
This was in clear contrast to pG8-Luc activity during ts2 infection,
which was more than two orders of magnitude lower. This result
indicates that E9 and D5 do not affect intermediate gene expres-
sion and that the importance of B1 at this stage is not common
among viral DNA replication proteins.
Next, the same transfection/infection protocol was performed
in L929-shBAF cells where BAF expression is stably depleted.
Interestingly, in these cells reporter gene expressionwas enhanced
to at least some degree regardless of the virus used (Fig. 2C).
Luciferase activity in WT, ts42, and ts24 infected L929-shBAF cells
was 2–3 folds greater than that observed for each of those viruses
in L929-shControl cells (Fig. 2D). Strikingly however, luciferase
activity in ts2 infected L929-shBAF cells was close to 40-fold
greater than that in L929-shControl cells (Fig. 2C and D). This
speciﬁc rescue of ts2-mediated intermediate gene expression in
BAF depleted cells suggests that the B1-BAF signaling axis is
important at this stage of the life cycle as well as during DNA
replication.
Depletion of B1 during WT vaccinia infection also impedes
transcription in a BAF-dependent manner
To further characterize the role of B1 during intermediate gene
regulation, we examined whether siRNA-mediated depletion of B1
Fig. 2. The defect in intermediate transcription is speciﬁc to ts2 and is rescued by depletion of BAF. (A) DNA replication assays. Total DNAwas isolated at 30 min and 24 h
after infection (MOI¼3) with WT, ts2, ts42, or ts24 at 37 1C, then quantiﬁed by qPCR. Data was obtained from two independent experiments, PCR ampliﬁed in duplicate. Data
is shown as a fold difference compared to the WT sample at 0.5 hpi. Error bars represent standard deviation. (B) Immunoblot analysis of BAF expression in L929 cells stably
depleted of BAF using speciﬁc shRNA. Lysates from equivalent numbers of cells were collected and analyzed using antibody against BAF. The total amounts of BAF in each
lane were quantiﬁed using a Bio-Rad Chemidoc XRS instrument. GAPDH level was used as loading control. (C) L929 cells stably expressing shBAF or shControl were
transfected with pG8-Luciferase for 7 h, then infected at 37 1C with WT, ts2, ts42 or ts24 at MOI¼3 in the presence of 50 μM AraC. Lysates were prepared at 16 h after
infection and assayed for luciferase activity. RLU shown is normalized to total protein measured by BCA assay. Data were obtained from three independent experiments
performed in triplicate wells. Data from a representative experiment is shown. Error bars represent standard deviation. (D) Data from the luciferase expression shown in
(C) was replotted as a fold difference between the shControl and shBAF cell lines for each virus. (*** indicates a p-value o0.05).
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virus. To establish a method for depletion B1 mRNA, L929 cells
were transfected with 100 nM of B1-speciﬁc or control siRNA for
24 h, followed by an infection with WT virus at MOI¼3 at 37 C for
4 h. Two B1-speciﬁc siRNA were tested. Lysates were collected and
RNA extracted for subsequent qPCR using primers speciﬁc to
the B1 ORF. Based on RT-qPCR results (Fig. 3A), the accumulation
of B1-speciﬁc transcripts was substantially reduced in siB1-
pretreated cells compared non-treated cells. The decrease in
B1-speciﬁc transcripts was 90% with siB1-1 and 70% with siB1-2.
Due to the greater depletion by siB1-1, we selected that siRNA for
use in subsequent studies.
To determine whether depletion of B1 results in diminished
intermediate gene expression, L929 were transfected with siB1 or
siControl for 12 h, then transfected with pG8-luc for 7 h before
infecting with WT vaccinia in the presence of AraC. Cells transfected
only with pG8-Luc and infected with ts2+AraC were included for
comparison purposes. To simultaneously investigate the involvement
of BAF in these studies, both L929-shControl and L929-shBAF cells
were employed. In L929-shControl, we found that depletion of B1
leads to a substantial decrease in the activity of the reporter gene
when compared to siControl-transfected cells or cells not treated with
any siRNA (Fig. 3B). Speciﬁcally, we observed an average decrease of
∼40-fold in luciferase activity, bringing the reporter activity to a level
very similar to that obtained during the ts2 infection. In L929-shBAF
cells, the depletion of BAF was able to rescue the loss of intermediate
gene expression caused by siB1 treatment as well as during ts2
infection. As in Fig. 2C and D, the fact that the loss of BAF speciﬁcallyenhances gene expression when B1 has been depleted further
supports our model that B1 is needed to repress the inhibitory
activity of BAF.
BAF immunoprecipitates pG8-Luc DNA and depletion of BAF rescues
viral intermediate gene expression at the transcriptional level
Although we have previously shown that BAF relocalizes to
transfected dsDNA by immunoﬂuorescence (Ibrahim et al., 2011)
and other studies have also shown BAF's DNA-binding capability
in vitro via biochemical and structural studies (Bradley et al., 2005;
Cai et al., 1998;Umland et al., 2000;Zheng et al., 2000), BAF's direct
interaction with DNA in an intact cell has yet to be demonstrated
by co-immunoprecipitation. Therefore, to validate that BAF
impairs gene expression through its direct DNA-binding activity,
we performed chromatin immunoprecipitation analysis in L929
cells stably expressing MCS empty vector (control) or FLAG-BAF.
Cells were transfected with 150 ng pG8-Luc plasmid for 24 h
followed by immunoprecipitation of BAF-DNA complexes. Bound
pG8-Luc DNA was analyzed by qPCR analysis using a pG8-Luc-
speciﬁc primer set which ﬂanks the G8 promoter region. In FLAG-
BAF-expressing cells, we observed an increase in pG8-Luc DNA
binding compared to control cells. Speciﬁcally, while the plasmid
DNA harvested for the input samples was similar between the MCS
and Flag-BAF expressing cells, following immunoprecipitation
the average difference in Ct was 5.3 Ct lower (Supp Fig. 2) in the
Flag-BAF cells and fold enrichment ∼40 fold higher than the
control cells (Fig. 4A). As all previous studies of BAF have shown
Fig. 3. Depletion of B1 impairs intermediate transcription following WT virus
infection, and can be rescued by BAF depletion. (A) L-929 cells were transfected
with 100 nM of siRNA siControl, siB1R-1, or siB1R-2. At 24 h post transfection, cells
were infected with WT virus at a MOI of 3 and total RNA harvested at 4 hpi.
Following reverse transcription, cDNA was quantiﬁed by qPCR. (B) L929 stably
expressing shBAF or shControl were transfected with 100 nM siRNA speciﬁc to B1
kinase (siB1-1) or siControl for 12 h, and then transfected with pG8-Luciferase for
7 h, then infected at 37 1C with WT virus at MOI¼3 in the presence of 50 μM AraC.
An infection of L929 with ts2 at MOI¼3 in the presence of AraC at 37 1C was also
performed. Lysates were prepared at 12 h after infection and assayed for luciferase
activity, and RLU normalized to protein level. Data were obtained from three
independent experiments performed in triplicate wells. Data from a representative
experiment is shown. Error bars represent standard deviation. (*** indicates a
p-value o0.05).
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curious as to whether BAF is preferentially binding the G8
promoter. Therefore, in addition to G8 promoter-speciﬁc primers,
we also utilized primers speciﬁc to the Neomycin resistance gene
on the opposite site of the plasmid and the cellular beta-actin
gene. We found that the Neo region of the plasmid and beta-actin
gene were immunoprecipitated with an efﬁciency almost equal to
the G8 promoter (Fig. 4B and C). These data support a model in
which BAF directly interacts with many, if not all, regions of the
plasmid construct during its impairment of gene expression. Such
a model would also be consistent with previous in vitro DNA
binding data and structural studies demonstrating that BAF binds
dsDNA in a sequence independent manner.
Kovacs et al. have previously shown that B1 impacts inter-
mediate gene expression at the level of transcription (Kovacs et al.,
2001). To conﬁrm and extend those results, we sought to deter-
mine whether B1's impact on transcript levels is BAF-dependent.
For these studies, L929-shControl and shBAF cells were transfected
with increasing amounts of pG8-Luc plasmid, then infected withWT or ts2 virus (MOI¼3) and incubated at 37 1C in the presence of
AraC. At 4 hpi, lysates were collected and RNA extracted for RT-
qPCR analysis using a luciferase-speciﬁc primer/probe set. In L929-
shControl cells, the accumulation of transcripts in ts2 infected cells
was reduced compared to WT infected cells (Fig. 4D). This
difference between ts2 and WT transcription was observed at all
plasmid concentrations, but was greatest at lower plasmid
amounts. As higher amount of plasmids were used, the difference
in transcripts between WT and ts2 infection shrinks. Next, upon
examining the impact of BAF depletion on transcripts synthesized
under the viral G8 promoter, we found that ts2-mediated tran-
scription was greater in L929-shBAF cells than in L929-shControl
cells. Most signiﬁcantly, when using 10 ng of DNA there was a
410-fold increase in transcript accumulation in L929-shBAF cell
as compared to ts2-infected L929-shControl cells. Together, these
data are consistent with our model that BAF can be a repressor of
viral gene expression at the transcriptional level if B1 is not
present to phosphorylate it.
The impact of BAF on gene expression is promoter dependent
In light of the ability of BAF to bind to dsDNA in a sequence
independent manner, we hypothesized that it may be capable of
impacting transcription of genes other than the pG8-Luc reporter
construct. To address this hypothesis, we began by asking (1) whether
the transcriptional role of BAF during gene expression is promoter
dependent and (2) whether the effect of B1 is also promoter
dependent. For these studies, plasmids were employed that express
ﬁreﬂy luciferase under a T7, CMV or a ‘minimal’ (minP) promoter,
which contains primarily a TATA box. T7-Luc was selected to be used
in conjunction with the recombinant vaccinia virus vTF7.3, which
expresses a wild-type B1 protein as well as the T7 polymerase. Thus,
transcription from the T7-Luc/vTF7.3 system will allow us to measure
reporter gene expression from transcription in the cytoplasm, but in a
manner independent of the vaccinia RNA polymerase and transcrip-
tion factors. The CMV-Luc and minP-Luc constructs contain a strong
and weak promoter, respectively, and are both activated by cellular
factors and therefore result in nuclear transcription. As BAF is present
in both the cytoplasm and nucleus, its impact on transcription in both
locations is of interest.
We began by examining the impact of the B1-BAF axis on T7-
mediated gene expression. L929-shBAF and shControl cells were
transfected as indicated with siB1 or siControl, then transfected
with T7-luciferase, and later infected with vTF7.3 virus at MOI¼3
in the presence of AraC for an additional 16 h before harvest.
As shown in Fig. 5A (left), siB1 treatment of L929-shControl cells
infected with vTF7.3 resulted in only a minor (2.5-fold) reduction
in T7-Luc reporter gene expression, contrary to what was observed
for pG8-Luc expression during WT infection (Fig. 3). When the
same transfection / infection study using T7-Luc was performed in
L929-shBAF cells, transcription activity rose modestly and was
similar in all cases regardless of B1 siRNA treatment regimen.
While these data suggest the B1-BAF axis contribute somewhat to
the level of T7-driven reporter activity observed, the magnitude of
their contribution is far less than what was observed when
studying the pG8-Luc reporter.
Next, we wanted to test whether the depletion of BAF can enhance
the expression of a reporter gene under a promoter transcribed in the
nucleus. L929-shControl and shBAF were transfected with two
different amount of CMV-Luc (immediate early promoter) or minP-
Luc plasmid for 24 h at 37 1C; then lysates were collected and
analyzed for luciferase activity. As shown in Fig. 5B, at both DNA
concentrations minP promoter-mediated luciferase expression was
enhanced only 2-fold in L929-shBAF cells, and the CMV promoter-
mediated luciferase expression (Fig. 5C) was similar regardless of BAF
level of expression. Based on the contrast between these data with the
Fig. 4. BAF immunoprecipitates pG8-Luc DNA in L929 cells and depletion of BAF rescues viral intermediate gene expression at the transcriptional level. (A) ChIP assays
were performed to determine the binding of BAF to DNA. L929 cells stably expressing MCS plasmid (control) or 3xFlag-BAF were transfected with 150 ng pG8-luciferase
plasmid for 24 h. Following ﬁxation and sonication, BAF-DNA complex was immunoprecipitated using anti-FLAG antibody and analyzed by quantitative PCR using primers
ﬂanking the G8 promoter (A) or Neomycin resistance gene (B) of pG8-Luc DNA or the beta-actin cellular gene (C). Data shown is a representative from three independent
experiments, each performed in duplicate. Error bars represent standard deviation. Data from the Raw Ct values (shown in Fig. S2) was plotted as fold enrichment relative to
MCS. (D) L929 cells stably expressing shBAF or shControl were transfected with 10, 100, and 500 ng of pG8-luciferase for 7 h, then infected with 37 1C with WT or ts2 at
MOI¼3 in the presence of AraC. Lysates were collected for RNA extraction and luciferase transcripts quantiﬁed by RT-qPCR. (*** indicates a p-value o0.05).
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promoter, it is evident that the B1-BAF axis affects transcription in a
gene speciﬁc manner. In our view, this speciﬁcity may be due to
differences in transcription factors and polymerases in play and/or
subcellular localization of the DNA in question and is discussed in
more detail below.Discussion
Vaccinia virus possesses multiple sophisticated mechanisms to
manipulate cellular signaling pathways and subvert host defenses
(Bowie and Haga, 2005; Moss and Shisler, 2001; Perdiguero and
Esteban, 2009). Studies on vaccinia-host interactions continue to
provide novel insights into the mechanisms employed by both virus
and host alike to achieve their respective goals during the course of aninfection. For example, the vaccinia B1 Ser/Thr kinase phosphorylates
the cellular factor BAF, which leads to the potent inhibition of BAF's
ability to bind and crossbridge viral DNA (Ibrahim et al., 2011; Wiebe
and Traktman, 2007). VRK1, a cellular homolog of B1, targets BAF on
the same residues as B1 (Nichols et al., 2006). It is now known that
the VRK1-BAF axis plays an important role in mitotic regulation
(reviewed in Valbuena et al., 2011), while the B1-BAF axis is needed
for viral DNA replication (Ibrahim et al., 2011; Wiebe and Traktman,
2007). Importantly, these studies revealed a novel function for BAF as
an antiviral effector capable of targeting vaccinia DNA in the cyto-
plasm. Currently, much remains to be learned about the contributions
of the B1 kinase to the viral lifecycle and speciﬁcally whether its
phosphorylation of BAF is needed to promote more than just viral
DNA replication.
The requirement of B1 for viral DNA replication, which itself is
needed for intermediate and late gene expression, is an obstacle to
Fig. 5. The role of B1 kinase and BAF in viral intermediate gene expression is
promoter dependent. (A) L929 stably expressing shBAF or shControl were
transfected with siRNA speciﬁc to B1 kinase (siB1-1) or siControl for 12 h, and
then transfected with 1 ng of T7-Luciferase for 7 hr, then infected with 37 1C with
Wt-VTF7.3 at MOI¼3 in the presence of AraC. Lysates were prepared at 12 h after
infection and assayed for luciferase activity, with RLU shown normalized to protein
level. (B and C) L929 stably expressing shBAF or shControl were transfected with
the indicated amounts of minP-Luc (B) or CMV-Luc (C). Lysates were prepared at
24 h after transfection and assayed for luciferase activity, with RLU shown normal-
ized to protein level. For all graphs, data were obtained from three independent
experiments performed in triplicate wells. Data from a representative experiment
is shown. Error bars represent standard deviation. (*** indicates a p-value o0.05).
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However, as reported by Kovacs et al. (2001), by using plasmid
reporters containing viral promoters to avoid the need for genomereplication, B1 was indeed found to be needed beyond DNA replica-
tion (Kovacs et al., 2001). However, the mechanism underlying B1's
contribution to gene expression was not fully deﬁned. Therefore, in
light of the importance of the B1-BAF axis for DNA replication, herein
we examined whether B1 was acting through this same pathway to
facilitate intermediate gene expression. As expected, the B1-deﬁcient
ts2 virus was only capable of activating the luciferase reporter gene
under the G8R promoter to o1% to that of the WT virus in L929 cells
(Fig. 1). The ts2 virus also exhibited a marked reduction of expression
from three other promoters in this study, demonstrating that B1's role
in transcription likely extends to intermediate gene expression in
general. A reduction in ts2-driven reporter activation as compared to
WT virus was also observed in other cell types including CV1, U2OS,
and BSC40 cells (Fig. S1A). The fact that L929 cells display the greatest
sensitivity in this assay was also found by Kovacs et al., and is the
reason why they were employed for the remainder of the study.
However, it is interesting to note that all of these cell lines express
similar amounts of BAF protein (Fig. S1B) indicating that either the
ts2-B1 protein or BAF exhibits cell type speciﬁc activity. Efforts to
tease out the mechanisms underlying these cell type speciﬁc differ-
ences is currently underway.
To directly test BAF's involvement in the transcriptional down-
regulation seen during ts2 infection we constructed L929 cells stably
depleted of BAF and performed luciferase reporter assays in those
cells (Fig. 2). Strikingly, cells with decreased levels of BAF exhibited a
40-fold increase in ts2-mediated gene expression as compared to
control L929 cells (Fig. 2D). While it is interesting to note that the
other viruses tested in this study (WT, ts42, and ts24) also exhibited
modestly increased reporter activation, the fact that ts2 was more
dramatically affected than other viruses demonstrates that the B1-
BAF axis impacts expression of the reporter gene. This conclusion is
also supported by our complementary data that siRNA-mediated
depletion of B1 from WT virus leads to a decrease in reporter
activation which can be rescued by the depletion of BAF (Fig. 3B).
Together, these data strongly suggest that in the absence of the B1
kinase, BAF is capable of impairing viral gene expression.
Finally, we have made progress towards determining the mechan-
ism underlying BAF's impact on viral gene expression. First, we
demonstrated that multiple regions of the plasmid co-immuno-
precipitates with BAF, supporting a model in which BAF binds foreign
DNA in a sequence independent manner, including interaction with
the promoter region of the reporter gene. Second, we directly tested
whether BAF was affecting transcription of the reporter gene by
measuring luciferase transcript accumulation during WT and ts2
infection. Using RT-qPCR, we observed that decreased transcript
levels observed during ts2 infection could be rescued by BAF
depletion, indicating that BAF functions at the level of gene tran-
scription. The speciﬁcity of BAF's action against transcription was also
examined using promoter-reporter constructs able to be expressed
independently of the vaccinia RNA polymerase. Interestingly, both
BAF and B1 depletions had little impact on a reporter under a T7
promoter during infection with vTF7.3, which expresses the T7
polymerase. Similarly, BAF depletion had little if any impact on either
minP or CMV driven reporter gene expression, both of which are
promoters responsive to RNA polymerase II and cellular transcription
factors. Together, these results provide the ﬁrst evidence that BAF can
function as a gene-dependent inhibitor of transcription, which can
itself be inactivated by the B1 kinase.
In regard to the mechanism of BAF's inhibition of viral gene
expression, previous studies have shown that BAF's ability to block
viral DNA replication requires its DNA binding and dimerization
activity (Ibrahim et al., 2011). These properties allow BAF to bind
and crossbridge/aggregate DNA (Bradley et al., 2005; Skoko et al.,
2009; Zheng et al., 2000), and also likely allow BAF to impair
transcription in the absence of B1. Precedent for this model can be
found in prokaryotes, where DNA crossbridging by dimeric proteins
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foreign DNA (Lucchini et al., 2006). Interestingly, the potency of
silencing due to H-NS binding is a function of the DNA binding afﬁnity
or other attributes of the transcription factors attempting to gain
access to the promoter bound by H-NS (Navarre et al., 2006, 2007),
consistent with a model in which the competition of repressor and
activator proteins determine the level of gene activation.
We posit that if BAF functions via a similar mechanism to H-NS
and is attempting to compete for DNA binding with transcriptional
activators it may, in part, explain the promoter-speciﬁc repression we
are observing. Following this logic, in the case of the vaccinia
promoters, the presence of BAF may be sufﬁcient to hinder recruit-
ment of some of the activators found to contribute to vaccinia
intermediate transcription. For example, the action of viral proteins
such as A8 and A23 (Sanz and Moss, 1999) as well as cellular factors
including G3BP/p137 (Katsafanas and Moss, 2004), TBP (Knutson et al.,
2006), and Yin-Yang 1 (YY1) (Broyles et al., 1999, Knutson et al., 2009)
have been linked to intermediate transcription and their access to the
promoter may be affected by BAF. In contrast, the fact that gene
expression from the T7, minP, and CMV promoters is similar in the
presence or absence of BAF suggests that binding of the transcription
factors and / or the polymerases to those promoters may not be
greatly impeded by BAF. Additionally, as the minP and CMV promoters
are transcribed in the nucleus, BAF's activity may be regulated
differently in that environment (such as by the nuclear kinase
VRK1), thus reducing BAF's ability to repress foreign DNA. This
possibility might also explain why we have found that the beta-actin
gene could be co-immunoprecipitated with BAF (Fig. 4C), while beta-
actin transcript levels remain unchanged in control or BAF-depleted
cells (data not shown). Future work to determine the relative
contribution of each of these possible regulatory mechanisms will be
of great interest.
Finally, we would be remiss if we did not point out that in each
of our experiments using L929-shBAF cells, the depletion of BAF
never led to a complete recovery of the transcriptional activity lost
due to impairment of the B1 kinase. We would suggest two
possible explanations for these observations. First, while BAF
depletion is signiﬁcant, it is still incomplete. The remaining BAF
may be capable of inhibiting intermediate gene expression.
Secondly, we posit that B1 may have substrates other than BAF
that are also needed for optimal transcription, which are mediat-
ing this difference in gene expression. In this regard one possible
candidate is the viral H5 protein, which is known to be phos-
phorylated by B1 and has been linked to transcriptional regulation
in other studies (Black et al., 1998; Brown et al., 2000; D’Costa
et al., 2008, 2010; Kovacs and Moss, 1996). Additional studies will
be needed to distinguish between these two possibilities.
In summary, these studies reveal that the B1-BAF signaling axis
impacts both DNA replication and intermediate gene expression.
Our observations demonstrate for the ﬁrst time that BAF can act as
a transcriptional repressor and provide the ﬁrst evidence that this
inhibitory activity can be regulated by phosphorylation of BAF.
Although this study focuses on vaccinia transcription in the
cytoplasm, the fact that a large fraction of BAF exists in the
nucleus and is targeted there by VRK1, suggest that post-
translational regulation of BAF probably has implications for
cellular gene expression as well.Materials and Methods
Cell culture, transfection and infection
All chemicals were purchased from Fisher Scientiﬁc or Sigma-
Aldrich unless otherwise stated. African green monkey BSC40
kidney epithelial cells, CV1, U2OS, and mouse ﬁbroblast L929 cellswere obtained from ATCC and maintained in Dulbecco's modiﬁed
Eagle's medium (DMEM) supplemented with 10% fetal bovine
serum (FBS; Atlanta Biologicals) and penicillin-streptomycin and
incubated at 37 1C in a 5% CO2 atmosphere.
Plasmids
For transfection experiments performed in the absence of
vaccinia infection, two plasmids expressing ﬁreﬂy luciferase were
used: CMV-Luc expresses luciferase under the CMV immediate
early enhancer promoter (pGL4.51[luc2/CMV/Neo], Catalog#
E1320), and minP-Luc expresses luciferase under a minimal
promoter containing only a TATA box (pGL4.26[luc2/min/Hygro],
Catalog# E8441). For transfection-infection experiments, pG8-
luciferase expresses luciferase under the viral intermediate G8
promoter (a generous gift from B. Moss, NIAID, Bethesda, MD), and
T7-luciferase (Promega) were used.
Plasmids containing A2, I1 and Consensus Intermediate pro-
moter sequences upstream of the ﬁreﬂy luciferase gene were
constructed as follows. PCR was performed using pG8-Luciferase
plasmid as a template and primers designed to include sequences
previously published of I1, A2 and Consensus promoters (Baldick
et al., 1992; Knutson et al., 2006; Yang et al., 2012). All three
promoters (in bold) were placed upstream of 18 bp homologous to
the 5′ end of ﬁreﬂy luciferase gene (in italics). Non-viral sequences
including three nucleotides followed by EcoRI restriction sites
were placed upstream of the promoter sequences (in lower case).
The upstream primers are A2L-Luc (5′ccggaattcGCAACGTCTA-
GAAATAAAATGTTTTTATATAAAAatggaagatgccaaaaac-3′), I1L-Luc
(5′-ccggaattcTTTGTATTTAAAAGTTGTTTGGTGAACTTAAATGGCagacg-
ccaaaaacataaag-3′) and Consensus-Luc (5′-ccggaattcTAATATATTTA-
AAATAAAAATTAATATTATAAAatggaagatgccaaaaac-3′). The down-
stream primer, Universal-Luc-3′ (5′-caggaattcttacacggcgatcttTc-3′),
is homologous to the 3′-end of the ﬁreﬂy luciferase ORF, and
contains an EcoRI site (lowercase) as well. PCR products ampliﬁed
using these primers were cloned into the pCRII-TOPO plasmid
(Invitrogen) using the EcoRI restriction and promoter identity
veriﬁed following DNA sequencing.
Viruses
The following viruses were used: wild-type vaccinia virus (WR
strain), the B1-deﬁcient ts2 virus (Condit et al., 1983; Rempel et al.,
1990; Rempel and Traktman, 1992), and vTF7.3 (Fuerst et al., 1986).
Recombinant virus ts2/B1 (Boyle and Traktman, 2004) was pro-
vided by Dr. Traktman (Medical College of Wisconsin). Viruses ts42
(E9 mutant) and ts24 (D5 mutant) were gifts from Dr. Rich Condit
(University of Florida). Stocks of all viruses were puriﬁed from
cytoplasmic lysates of infected BSC40 cells by ultracentrifugation
through 36% sucrose; and quantiﬁed by plaque assay titration on
BSC40 cells.
Production of cells stably overexpressing BAF
The stable overexpression of BAF in L929 cells was performed
by using a lentivirus expressing 3XFlag-BAF (plasmids were a kind
gift from Dr. Paula Traktman (Molitor and Traktman, 2013)).
Speciﬁcally, 293 T cells were transfected with pHM-3XFlag-BAF
or pHM-MCS plasmid (Mostoslavsky et al., 2006; Ory et al., 1996)
with a combination of viral packaging plasmids pVSV-G, pTat,
pREV and pGag/Pol. The next day, media was replaced with fresh
media containing 5 mM Sodium Butyrate. Eight hours later fresh
media containing 10 mM HEPES pH7.4 was added for additional
12 h. Next, media containing lentivirus was ﬁltered through a
0.45 μm sterile ﬁlter, and polybrene (8 μg/ml) was added and
stored at 80 1C. For transduction, L929 cells were seeded in
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replaced with 1 mL of lentivirus supernatant. After 24 h, medium
was replaced with fresh media for additional 24 h. Cells were then
grown in media containing 200 μg/ml of hygromycin to select for
stable lentiviral integration.Production of cells stably depleted of BAF
The stable depletion of BAF was performed using a lentivirus
expressing a BAF-speciﬁc short hairpin RNA (shRNA) or control
(scrambled) shRNA as previously described (Ibrahim et al., 2011),
with the exception that transduced cells were selected with 15 ug/
ml of puromycin. To express shRNA speciﬁc to murine BAF mRNA,
the primers mBAFsense (5′-TGGCTTATGTGGTCCTTGGCTTCAAGA-
GAGCCAAGGACCACATAAGCCTTTTTGGAAAC-3′) and mBAFanti-
sense (5′-TCGAGTTTCCAAAAAGGCTTATGTGGTCCTTGGCTCTCTTG-
AAGCCAAGGACCACATAAGCCA-3′) were annealed and cloned into
the pLL3.7 as previously described (Wiebe and Traktman, 2007).Luciferase assays
Transfection-Infection experiments: L929 cells seeded at 2105
per well of a 12-well plate were transfected using Lipofectamine
2000 (Invitrogen) with 10 ng of pG8-Luc DNA per well. The
plasmid-Lipofectamine transfection complexes were prepared as
follows:130 ng of pG8-luciferase and 1 μl of Lipofectamine 2000
were combined in 2.3 mL of DMEM; and 200 μl of the transfection
mixture was used per well. Cells were incubated at 37 1C in a 5%
CO2 atmosphere for 7 h to allow for plasmid introduction into the
cells, which were then infected with vaccinia virus at a multiplicity
of infection (MOI) of 3 in media containing 50 μM AraC and placed
back in the incubator for additional 18 h. Cells were then washed
twice with phosphate-buffered saline(PBS) (10 mM Na2H-
PO47H2O, 1 mM KH2PO4, 2 mM KCl, 140 mM NaCl [pH 7.4]),
then lysed in 300 μl of 1X Reporter Lysis buffer (Promega) by two
freeze-thaw cycles. The luciferase activity was measured using
50 μl of lysate for 100 μl of luciferase assay substrate buffer in a
Berthold multiwell Luminometer.
Transfection alone: L929 cells were seeded at 2105 per well of
a 12-well plate, and the next day they were transfected using
Lipofectamine 2000 (2 μl per μg DNA; Invitrogen) with CMV-Luc or
minP-luciferase for additional 12 h. Cells were washed twice with
PBS, and then lysed with 300 μl of 1X Reporter Lysis buffer
(Promega), and freeze-thaw twice. The luciferase activity was
measured using 50 μl of lysate and 100 μl of luciferase assay
substrate buffer in a Berthold multiwell Luminometer. Fireﬂy
luciferase expression was normalized to relative total protein level
in each lysate. Protein level in each lysate was quantiﬁed by BCA
protein assay (Thermo Scientiﬁc).Immunoblot analysis
L929 and L929 stably expressing speciﬁc shRNA were freshly
collected in 300 μl of SDS sample buffer (100 mM Tris pH6.8, 2% β-
mercaptoethanol, 2% SDS, 32.5% glycerol, bromophenol blue)
supplemented with 10 units of Benzonase. Lysate volume equiva-
lent to 105 cells were subjected to SDS-polyacrylamide gel electro-
phoresis (PAGE) on a 18% gel, transferred to PVDF, and incubated
with primary against BAF (Wiebe and Traktman, 2007), and rabbit
secondary antibodies. Blots were developed with chemilumines-
cent reagents, and quantiﬁed by a Bio-Rad Chemidoc XRS instru-
ment to verify that BAF expression had been depleted 485%.B1 siRNA transfection/infection
B1-speciﬁc and control siRNAs were designed and ordered
from Dharmacon. The B1-1siRNA sense sequence is 5′–CAAUAUG-
CACCUAGAGAAUUU-3′ and the B1-2 siRNA sense sequence is
5′–GCCCAAAGCUAACGGAUCAUU-3′. The siControl sense strand
sequence is 5′–CAGUCGCGUUUGCGACUGGUU-3′. L-929 cells were
transfected with 100 nM of siRNA Control, siB1R-1, or siB1R-2
using RNAimax (Life Technologies) as per manufacturer's protocol.
16–24 h post transfection cells were infected with WT virus at an
MOI of 3 and harvested for B1R mRNA at 4 hpi. RNA was extracted
using TRIzol reagent, puriﬁed with Aurum Total RNA mini kit
(Biorad), reverse transcribed to generate cDNA (Applied Biosys-
tems, High Capacity cDNA Reverse Transcription Kit), and treated
with 0.5 μg/ml RNase A prior to qPCR analysis.
qPCR
qPCR performed on B1R cDNA was done using TaqMan master
mix (Applied Biosystems) and 900 nM of primers B1R F (5′-
AATCAATGGGTCGTTGGACCAT-3′) and B1R R (5′-AATACATCATTTT-
TATCTCGGGTTTCGATTGC-3′), and 250 nM B1R probe (5′–56-FAM/
AG GTG CAG ATC TAG ATG CGG TGA TCA /3IABkFQ-3′), speciﬁc to
the vaccinia virus B1R gene. To measure viral DNA replication, DNA
was extracted from the cells with the QIAamp DNA Blood Mini Kit
(Qiagen) and treated with 5 μg/ml RNase A. Viral DNA replication
was quantiﬁed using SYBR green PCR mix (Applied Biosystems)
with primers speciﬁc to the vaccinia virus HA gene at a concen-
tration of 900 nM each (HA F: 5′-CATCATCTGGAATTGTCACTA
CTAAA-3′ and HA R: 5′-ACGGCCGACAATATAATTAATGC-3′).
ChIP Assays
L929 cells (107) stably expressing speciﬁc shRNA were trans-
fected with 150 ng pG8-Luc plasmid for 24 h. Cells were cross-
linked with 1% formaldehyde for 10 min at room temperature
followed by quenching with 0.75% glycine. Cell lysis was done
using FA lysis buffer (50 mM HEPES-KOH pH 7.5, 140 mM NaCl,
1 mM EDTA pH 8, 1% TritonX-100, 0.1% sodium deoxycholate, 0.1%
SDS, and protease inhibitor (Complete, Roche)). Lysates were
sonicated with Misonix XL-2000 Sonicator for 1010 s at power
setting 3 (output wattage 6) followed by centrifugation at 8000 g
for 1 min. A fraction (6%) of the supernatant was used as ‘input’.
Clariﬁed lysates were then incubated at 4 1C overnight with 2 μg of
anti-FLAG antibody (F7425, Sigma) and an equal volume of RIPA
buffer (50 mM Tris.HCl pH 8, 150 mM NaCl, 2 mM EDTA pH 8, 1%
NP-40, 0.5% sodium deoxycholate, 0.1% SDS, and protease inhibi-
tor). To each sample, 10 mL of Dynabeads Protein G (10003D,
Novex) were added and incubated on a rotator at 4 1C for 2 h.
Beads were washed 3 times with wash buffer (20 mM Tris–HCl pH
8.0, 150 mM NaCl, 2 mM EDTA pH 8, 1% Triton X-100, and 0.1%
SDS), and once with ﬁnal wash buffer (20 mM Tris–HCl pH 8.0,
500 mM NaCl, 2 mM EDTA pH 8, 1% Triton X-100, and 0.1% SDS).
Bound complexes were eluted from the beads with elution buffer
(100 mM NaHCO3 and 1% SDS) by incubating at 30 1C for 20 min.
Crosslinking was reversed by overnight incubation at 60–65 1C in
the presence of 10 mg/ml RNase A and 1 mg/ml Proteinase K. DNA
was puriﬁed using Zymoclean Gel DNA Recovery Kit (D4002, Zymo
Research). Immunoprecipitated and input material was analyzed
by quantitative PCR (StepOne Plus Real Time PCR, Applied Biosys-
tems) using SYBR green PCR mix (Applied Biosystems) with three
different primers sets as followed: G8Pro ChIP Fwd (5′-
CTTCGTGGATCCTGTAGAACG-3′) and G8Pro ChIP Rev (5′-CCA-
TCTTCCAGCGGATAGAATG-3′) which ﬂank the G8 promoter
of pG8-Luc DNA; Neo Fwd (5′–CTTGCTCCTGCCGAGAAAGT-3′)
and Neo Rev (5′–TTCGCTTGGTGGTCGAATG-3′); and ActinB Fwd
N. Ibrahim et al. / Virology 444 (2013) 363–373372(5′–GGTCATCACTATTGGCAACG-3′) and ActinB Rev (5′–CGTCA-
CACTTCATGATGGAATTG-3′). Serial dilutions were also included
in each qPCR run and used to develop a standard curve and
determine the PCR efﬁciency of the primer sets in that experiment
set. The efﬁciency (E) is calculated as such: E¼10(1/slope). Fold
enrichment was calculated relative to negative control sets as
such: fold enrichment¼E(ΔCttarget – ΔCtcontrol).
Statistics
Error bars shown represent one standard deviation from the
mean. The p-values indicated were calculated using the Students
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